Leveraging tele-consultation technology to improve service efficiency Test results available within the same day at the earliest

UMP Healthcare Holdings Limited (“UMP” or the “Group”; SEHK stock code: 722) announced today in order to meet market demand for COVID-19 testing, the Group will provide Deep Throat Saliva Test service at 10 of its general practice clinics, with results available within the same day at the earliest. On top of its provision of physical consultation services, the Group leverages its virtual care platform to provide tele-consultation services as another convenient option for pre-testing doctor assessment to enhance efficiency of services.

Effective from 9 July 2020, Deep Throat Saliva Test service will be available at 10 of UMP’s general practice clinics. The packaged service includes one-time doctor consultation, Deep Throat Saliva Test and results report. Test results will be available within the same working day at the earliest with sample submitted by 3pm upon doctor consultation. Testing will be conducted by laboratory with test results to be informed via email.

Leveraging UMP’s technological advantages to improve efficiency of COVID-19 testing

As doctor referral is a prerequisite for conduction of COVID-19 tests, pre-testing doctor assessment is of utmost importance. Leveraging its continuous investment in technological innovation, UMP’s virtual care platform provides tele-consultation services to allow clients in need to make medical appointments and conduct real-time doctor tele-assessment through mobile app with online fee settlement. The service simplifies the overall appointment process, while delivery services of testing kits will be available to allow substantial reduction of pre-assessment waiting at clinics and provide the general public with a fast and convenient option for COVID-19 tests.